Anti-Factor XII antibody - C-terminal
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Polyclonal Factor XII antibody. C-terminal. Suitable for WB, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 4 publications. Immunogen corresponding to Recombinant Fragment Protein within Human F12.
View Alternative Names
Coagulation factor XII, Hageman factor, HAF, F12
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Factor XII antibody - C-terminal (AB196670)
Immunohistochemical analysis of paraffin-embedded rat kidney tissue labeling Factor XII with ab196670 at 1/50 dilution.
- WB
Supplier Data
Western blot - Anti-Factor XII antibody - C-terminal (AB196670)
All lanes:
Western blot - Anti-Factor XII antibody - C-terminal (ab196670) at 1/500 dilution
Lane 1:
HepG2 cell extract
Lane 2:
MCF7 cell extract
Lane 3:
SW480 cell extract
Lane 4:
Mouse liver extract
Predicted band size: 67 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein helps control blood coagulation processes as part of a larger network of interacting proteins that includes contact activation factors. Factor XII activates not only the coagulation cascade but also pathways involved in fibrinolysis inflammation and bradykinin formation. It triggers the kallikrein-kinin system and leads to the generation of bradykinin a peptide known to induce vascular permeability and inflammation.
Pathways
The involvement of Factor XII spans the intrinsic coagulation pathway and the kallikrein-kinin system. It interacts with several other coagulation factors such as Factor XI and prekallikrein to advance the clotting process. The protein initiates the intrinsic blood coagulation pathway by converting Factor XI to Factor XIa in the presence of negatively charged surfaces. It links to the fibrinolytic pathway and can indirectly activate plasminogen through interactions that generate plasmin.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
British journal of pharmacology 181:3760-3778 PubMed38872396
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neuroscience 413:294-307 PubMed31181367
2019
Applications
Unspecified application
Species
Unspecified reactive species
RNA (New York, N.Y.) 25:255-263 PubMed30463937
2018
Applications
Unspecified application
Species
Unspecified reactive species
Circulation 134:141-52 PubMed27354285
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com